Discovery in Our Labs
The Winthrop P. Rockefeller Cancer Institute directs cancer research for the University of Arkansas for Medical Sciences (UAMS) and its affiliated institutions. Cancer Institute scientists are committed to reducing cancer incidence, mortality and morbidity in Arkansas and the surrounding region.
The Cancer Institute accomplishes its goals through focused research programs, shared resources and multidisciplinary disease-specific committees.
The Cancer Institute’s approach is simple: Discovery in our labs leads to the development of new treatment strategies, which are then delivered to the patients in our clinics. The bottom line for our patients is that our research fuels innovative treatment options.
Our Research
Research Programs
All research at the Cancer Institute is organized into four distinct research programs to maximize and nurture scientific collaborations and productivity.
Learn More
Clinical Research
Clinical research conducted at the Cancer Institute focuses on cancer prevention, screening, treatment and support.
Learn More
Shared Resources
Shared resources provide Cancer Institute members with cost-effective access to specialized technologies, methodologies and quality control.
Learn More
Research Training and Education Core
Numerous educational and training opportunities are available for cancer researchers from the Cancer Institute, the Translational Research Institute and Research Administration.
Learn More
Internal Funding
Internal funds available to support cancer research are updated monthly.
Learn More
Membership
The mission of the Winthrop P. Rockefeller Cancer Institute is to translate today’s discoveries into tomorrow’s strategies to effectively reduce cancer throughout its continuum fr
Learn MoreResearch: UAMS’ Analiz Rodriguez, M.D., Ph.D., Selected for Diversity in Clinical Trials Career Development Program
LITTLE ROCK — The Bristol Myers Squibb Foundation (BMSF), along with its partners National Medical Fellowships and the American Association for Cancer Research, selected University of Arkansas for Medical Sciences (UAMS) neurosurgeon Analiz Rodriguez, M.D., Ph.D., to participate in its Diversity in Clinical Trials Career Development Program.
More News
UAMS Receives $18.9 Million NIH Award to Address Health Disparities
LITTLE ROCK — The University of Arkansas for Medical Sciences (UAMS) has received $18.9 million from the National Institutes of Health (NIH) to support new research and interventions that will focus on reducing cancer and cardiovascular disease disparities among people who live in rural areas and African American populations across Arkansas. The five-year award from…
Read more
UAMS Biostatistics Contributes to Groundbreaking ANCHOR Study
The UAMS Department of Biostatistics played a key role in a successful national clinical trial to treat anal cancer in persons living with HIV. Jeannette Y. Lee, Ph.D., UAMS biostatistics professor and biostatistics leader for the Winthrop P. Rockefeller Cancer Institute at UAMS, served as the statistical center director for the National Cancer Institute’s (NCI)…
Read more
UAMS Researchers See 12% Increase in Grant Funding for FY2021
LITTLE ROCK — The University of Arkansas for Medical Sciences (UAMS) and its affiliate research institutions saw research funding grow by 12.2% this past year, with $177.4 million in grants by the end of the fiscal year on June 30. It is the second consecutive year with double-digit increases in research funding that comes from…
Read more
UAMS Participating in National Breast Cancer Screening Trial
The UAMS Winthrop P. Rockefeller Cancer Institute is participating in the National Cancer Institute’s TMIST (Tomosynthesis Mammographic Imaging Screening Trial). The study compares two standard breast cancer screening methods — tomosynthesis (3D) mammograms and digital (2D) mammograms — and is designed to help researchers determine whether one method is better than the other at finding…
Read moreWant to read more stories like these?